Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax

NCT07533136 is registered in ClinicalTrials.gov with Walter Reed Army Institute of Research (WRAIR) as lead sponsor.

NCT NCT07533136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07533136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax
Lead sponsor
Walter Reed Army Institute of Research (WRAIR)
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
May 30, 2029
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uncomplicated p. vivax mono-infection